Microbot Total Assets from 2010 to 2024
| MBOT Stock | USD 0.92 0.01 1.10% |
Total Assets | First Reported 1991-12-31 | Previous Quarter 8.9 M | Current Value 8.3 M | Quarterly Volatility 15.9 M |
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.7 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 302, Dividend Yield of 0.0 or PTB Ratio of 3.9. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
Microbot | Total Assets |
Latest Microbot Medical's Total Assets Growth Pattern
Below is the plot of the Total Assets of Microbot Medical over the last few years. Total assets refers to the total amount of Microbot Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Microbot Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Microbot Medical's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 8.33 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Microbot Total Assets Regression Statistics
| Arithmetic Mean | 19,620,195 | |
| Geometric Mean | 15,707,037 | |
| Coefficient Of Variation | 61.56 | |
| Mean Deviation | 10,218,921 | |
| Median | 17,300,000 | |
| Standard Deviation | 12,077,396 | |
| Sample Variance | 145.9T | |
| Range | 38.2M | |
| R-Value | (0.47) | |
| Mean Square Error | 122.8T | |
| R-Squared | 0.22 | |
| Significance | 0.08 | |
| Slope | (1,261,528) | |
| Total Sum of Squares | 2042.1T |
Microbot Total Assets History
Other Fundumenentals of Microbot Medical
Microbot Medical Total Assets component correlations
Click cells to compare fundamentals
About Microbot Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Microbot Medical income statement, its balance sheet, and the statement of cash flows. Microbot Medical investors use historical funamental indicators, such as Microbot Medical's Total Assets, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may use each financial statement separately, they are all related. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Microbot Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Microbot Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Microbot Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 8.3 M | 7.9 M | |
| Intangibles To Total Assets | 0 | 0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Microbot Medical Correlation against competitors. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Microbot Stock analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Microbot Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Return On Assets (0.69) | Return On Equity (1.82) |
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbot Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.